Literature DB >> 27713533

Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia.

V Madan, P Shyamsunder, L Han, A Mayakonda, Y Nagata, J Sundaresan, D Kanojia, K Yoshida, S Ganesan, N Hattori, N Fulton, K T Tan, T Alpermann, M C Kuo, S Rostami, J Matthews, M Sanada, L-Z Liu, Y Shiraishi, S Miyano, E Chendamarai, H A Hou, G Malnassy, T Ma, M Garg, L W Ding, Q Y Sun, W Chien, T Ikezoe, M Lill, A Biondi, R A Larson, B L Powell, M Lübbert, W J Chng, H F Tien, M Heuser, A Ganser, M Koren-Michowitz, S M Kornblau, H M Kantarjian, D Nowak, W K Hofmann, H Yang, W Stock, A Ghavamzadeh, K Alimoghaddam, T Haferlach, S Ogawa, L Y Shih, V Mathews, H P Koeffler.   

Abstract

Entities:  

Year:  2016        PMID： 27713533      PMCID： PMC7609306          DOI： 10.1038/leu.2016.237

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
Correction to: Leukemia (2016) 30, 1672–1681; doi:10.1038/leu.2016.69 Following the publication of this article, the authors have noted that three genes: FLT3, NRAS and ARID1A (each with mutational frequency of 5%) have been incorrectly labelled in Figure 4a showing the mutational landscape of APL relapse.
Figure 4

Spectrum of somatic mutations at APL relapse. (a) Matrix displays top 15 genes recurrently mutated at relapsed APL. Each column represents a relapse sample. Genes are arranged according to decreasing mutational frequencies from top to bottom. Right panel illustrates the number of mutations for all genes. Only those relapse samples that harbor mutations of top 15 genes are included in the matrix.

Spectrum of somatic mutations at APL relapse. (a) Matrix displays top 15 genes recurrently mutated at relapsed APL. Each column represents a relapse sample. Genes are arranged according to decreasing mutational frequencies from top to bottom. Right panel illustrates the number of mutations for all genes. Only those relapse samples that harbor mutations of top 15 genes are included in the matrix. Below is the corrected figure. The authors confirm that the above mislabeling has no impact on the conclusions made and wish to apologize for any inconvenience caused.
  11 in total

1.  Molecular landscape of acute promyelocytic leukemia at diagnosis and relapse.

Authors:  Annette Fasan; Claudia Haferlach; Karolina Perglerovà; Wolfgang Kern; Torsten Haferlach
Journal:  Haematologica       Date:  2017-03-24       Impact factor: 9.941

Review 2.  A comprehensive review of genetic alterations and molecular targeted therapies for the implementation of personalized medicine in acute myeloid leukemia.

Authors:  Anuradha Kirtonia; Gouri Pandya; Gautam Sethi; Amit Kumar Pandey; Bhudev C Das; Manoj Garg
Journal:  J Mol Med (Berl)       Date:  2020-07-03       Impact factor: 4.599

3.  Sequential adaptive changes in a c-Myc-driven model of hepatocellular carcinoma.

Authors:  James M Dolezal; Huabo Wang; Sucheta Kulkarni; Laura Jackson; Jie Lu; Sarangarajan Ranganathan; Eric S Goetzman; Sivakama S Bharathi; Kevin Beezhold; Craig A Byersdorfer; Edward V Prochownik
Journal:  J Biol Chem       Date:  2017-04-21       Impact factor: 5.157

Review 4.  Recent advances in acute promyelocytic leukaemia.

Authors:  Chin-Hin Ng; Wee-Joo Chng
Journal:  F1000Res       Date:  2017-07-28

5.  ASXL2 regulates hematopoiesis in mice and its deficiency promotes myeloid expansion.

Authors:  Vikas Madan; Lin Han; Norimichi Hattori; Weoi Woon Teoh; Anand Mayakonda; Qiao-Yang Sun; Ling-Wen Ding; Hazimah Binte Mohd Nordin; Su Lin Lim; Pavithra Shyamsunder; Pushkar Dakle; Janani Sundaresan; Ngan B Doan; Masashi Sanada; Aiko Sato-Otsubo; Manja Meggendorfer; Henry Yang; Jonathan W Said; Seishi Ogawa; Torsten Haferlach; Der-Cherng Liang; Lee-Yung Shih; Tsuyoshi Nakamaki; Q Tian Wang; H Phillip Koeffler
Journal:  Haematologica       Date:  2018-08-09       Impact factor: 9.941

Review 6.  Clonal evolution of acute myeloid leukemia from diagnosis to relapse.

Authors:  Sebastian Vosberg; Philipp A Greif
Journal:  Genes Chromosomes Cancer       Date:  2019-09-03       Impact factor: 5.006

Review 7.  Acute Promyelocytic Leukemia: Update on the Mechanisms of Leukemogenesis, Resistance and on Innovative Treatment Strategies.

Authors:  N I Noguera; G Catalano; C Banella; M Divona; I Faraoni; T Ottone; W Arcese; M T Voso
Journal:  Cancers (Basel)       Date:  2019-10-18       Impact factor: 6.639

8.  Tumor suppressor function of WT1 in acute promyelocytic leukemia.

Authors:  Matthew J Christopher; Casey D S Katerndahl; Hayley R LeBlanc; Tyler T Elmendorf; Vaishali Basu; Margery Gang; Andrew J Menssen; David H Spencer; Eric J Duncavage; Shamika Ketkar; Lukas D Wartman; Sai Mukund Ramakrishnan; Christopher A Miller; Timothy J Ley
Journal:  Haematologica       Date:  2022-01-01       Impact factor: 9.941

9.  Targeting BRD9 by I-BRD9 efficiently inhibits growth of acute myeloid leukemia cells.

Authors:  Lixin Zhou; Qi Yao; Hui Li; Jieping Chen
Journal:  Transl Cancer Res       Date:  2021-07       Impact factor: 1.241

10.  The PML-RARA fusion is not detectable in historical blood samples of acute promyelocytic leukaemia patients.

Authors:  William G Dunn; Muxin S Gu; Margarete A Fabre; Jonathan Cooper; Josep F Nomdedeu; Laura Koumas; Katerina Nicolaou; Jiangxiang Chi; Paul Costeas; George S Vassiliou
Journal:  Ann Hematol       Date:  2021-03-01       Impact factor: 3.673
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.